Filing Flows › Chemours (CC) › Guidance history
Chemours (CC) guidance history: what it guided and what it reported
Chemours gave guidance in 4 earnings releases on file since May 5, 2026. Its releases raised guidance 0 times and lowered it twice.
Capital expenditures
The GAAP figure from the filings is shown for each period reported; it is not judged against the guide, which may leave items out (one-off payments, acquisitions).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | $75.0M–$85.0M (Nov 2, 2026) | — | to be reported | — |
| Q3 2026 | $65.0M (Aug 4, 2026) | $51.0M (GAAP) | not judged | — |
| FY2026 | $275M–$325M (May 5, 2026) → lowered $250M–$280M (Aug 4, 2026) | — | to be reported | — |
| Q2 2026 | $50.0M (May 5, 2026) | $44.0M (GAAP) | not judged | — |
Free cash flow
The GAAP figure from the filings is shown for each period reported; it is not judged against the guide, which may leave items out (one-off payments, acquisitions).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q3 2026 | $50.0M (Aug 4, 2026) | $98.0M (GAAP) | not judged | — |
| Q2 2026 | $100M (May 5, 2026) | $114M (GAAP) | not judged | — |
Interest expense
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $3.0M (Nov 5, 2026) | — | to be reported | — |
Adjusted EBITDA
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q4 2026 | $160M–$185M (Nov 2, 2026) | — | to be reported | — |
| Q3 2026 | $175M–$205M (Aug 4, 2026) | — | — | — |
| FY2026 | $800M–$900M (May 5, 2026) → lowered $775M–$825M (Aug 4, 2026) → lowered $775M–$800M (Nov 2, 2026) | — | to be reported | — |
| Q2 2026 | $220M–$250M (May 5, 2026) | — | — | — |
The latest quarter
Chemours, Q3 2026: revenue $1.5B (+3% year over year), operating margin 14.4%, net earnings $196M, operating cash flow $149M. The chart follows the revenue to costs, profit and cash.
Questions
Does Chemours beat its guidance?
Chemours gave guidance in 4 earnings releases on file since May 5, 2026. Its releases raised guidance 0 times and lowered it twice.
How often does Chemours raise guidance?
Its earnings releases raised guidance 0 times and lowered it twice since May 5, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.